AmerisourceBergen Global Services in the news

Cencora leverages AI for automating benefit verification and improving medication adherence through predictive analytics, optimizing patient access and health outcomes.

AmerisourceBergen Corp. rebranded as Cencora, unifying its global operations and investing in pharmaceutical distribution and services, while also renaming its foundation and venture fund.

Cencora, formerly AmerisourceBergen, helps biopharma partners with pharmaceutical development and commercialization, focusing on cell and gene therapies, AI adoption, Inflation Reduction Act navigation, and European market expansion.

AmerisourceBergen has rebranded to Cencora and pledged $5 million to its foundation to support healthcare innovation and global health initiatives.

AmerisourceBergen rebranded as Cencora, unifying its global operations, investing in pharmaceutical services, and launching a $5 million grant program for global healthcare access, with an initial $500,000 to the UNICEF Health Fund.

AmerisourceBergen rebranded as Cencora, unifying its global operations and focusing on pharmaceutical distribution and services, marked by a name and ticker change on the NYSE, and a significant donation to its charitable foundation.

Tenet Healthcare has hired former AmerisourceBergen executive Sun Park to take over as CFO in January 2024.

AmerisourceBergen is piloting a telehealth solution with SteadyMD to enable independent pharmacies to offer 'Test to Treat' services and on-demand physician consultations.

AmerisourceBergen is partnering with TPG Capital to acquire OneOncology for $2.1 billion, with an initial 35% ownership stake and a path to full acquisition within three to five years.

AmerisourceBergen partners with TPG Capital to acquire OneOncology, the largest independent community oncology network, for $2.1 billion, with AmerisourceBergen taking an initial 35% stake.

TPG and AmerisourceBergen are acquiring OneOncology, a network of independent community oncology practices, for $2.1 billion.

TPG and AmerisourceBergen are acquiring OneOncology, a network of oncology practices, for $2.1 billion, with AmerisourceBergen taking a minority stake to expand its specialty solutions.

AmerisourceBergen is rebranding to Cencora in late 2023 to unify its global pharmaceutical services and distribution identity.

AmerisourceBergen will rebrand as Cencora in the latter half of 2023 to unify its global identity and reflect its evolving role in healthcare.

AmerisourceBergen Corp. will change its name to Cencora in the second half of this year to support its global expansion and diversification beyond drug distribution.

AmerisourceBergen acquired PharmaLex to enhance its global commercialization and regulatory support for biopharma companies.

AmerisourceBergen acquired PharmaLex to enhance its specialty services and global pharma manufacturer services.

Outlook Therapeutics engaged AmerisourceBergen to manage logistics and distribution for its wet AMD treatment ONS-5010 in the US and potentially internationally.

AmerisourceBergen's Lithuanian branch is expanding, planning to create over 400 new jobs and celebrating its fifth anniversary.

A strategic partnership has been formed to handle the logistics, distribution, and commercial support for the upcoming launch of a new retinal disease treatment.